Immuron (Warrant)
+$0.00 (+0.01%) As of 3:03 PM UTC today
Why Robinhood?
You can watch IMRNW and buy or sell other stocks, options, and ETFs commission-free!
About IMRNW
Immuron Ltd. engages in the research and development of oral immunotherapy, and product sales which focuses on bovine-colostrum with antibodies of choice for the treatment and prevention of a range of infectious and immune modulated diseases. It operates through the following segments: Research and Development, and HyperImmune Products.The Research and Development segment involves the R&D projects performed in Australia, Israel, and United States.
CEO
Jerry Kanellos, PhD
Employees
—
Headquarters
Carlton, Victoria (VIC)
Founded
1994
IMRNW Key Statistics
Market Cap
—
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
558.10
High Today
$1.34
Low Today
$1.34
Open Price
$1.34
Volume
150.00
52 Week High
$11.19
52 Week Low
$0.2113